Leadership Overview
Varian has 6 executives leading key functions including operational processes, medical affairs, radiation oncology, multi-disciplinary oncology, and proton solutions.
Committed to advancing cancer care through innovative technology, Varian delivers sophisticated radiotherapy and software solutions to improve patient outcomes across global healthcare markets.
Committed to advancing cancer care through innovative technology, Varian delivers sophisticated radiotherapy and software solutions to improve patient outcomes across global healthcare markets.
Leadership Roles at Varian
Faisal Siddiqui - Vice President and Chief Operating Officer - Processes
Faisal Siddiqui, the Vice President and Chief Operating Officer - Processes at Varian, directs the optimization of internal manufacturing workflows and global supply chain efficiency. Overseeing the integration of lean methodologies, the Chief Operating Officer - Processes ensures that production cycles for radiotherapy and brachytherapy devices meet rigorous quality standards. This leadership role involves coordinating cross-functional teams to streamline operational throughput across international facilities. By refining core business processes, Faisal Siddiqui directly impacts the scalability of medical device manufacturing. Siddiqui maintains alignment with corporate objectives by monitoring performance metrics and implementing systemic improvements. Through the application of advanced process engineering, the Chief Operating Officer - Processes supports the delivery of high-precision cancer treatment technology to clinical partners worldwide, ultimately driving operational excellence and sustaining the competitive market position of the organization within the medical device sector.
Sasa Mutic - President, Radiation Oncology Solutions
Sasa Mutic, the President, Radiation Oncology Solutions at Varian, drives the development and commercialization of advanced radiotherapy and radiosurgery platforms. Overseeing the product lifecycle for core oncology hardware, the President, Radiation Oncology Solutions ensures that technological advancements address the evolving needs of cancer centers. This leadership role involves managing large-scale market expansion strategies across diverse geographic regions. By prioritizing innovation in imaging and treatment delivery, Sasa Mutic directly impacts the precision of cancer care. Mutic coordinates with engineering and sales teams to maintain a robust pipeline of clinical solutions. Through the strategic direction of the radiation oncology portfolio, the President, Radiation Oncology Solutions secures the market leadership of the company. This role involves constant evaluation of clinical outcomes to refine product offerings, ensuring that the organization remains at the forefront of medical technology while supporting the global fight against cancer.
Andrew Shogan - President, Multi-Disciplinary Oncology
Andrew Shogan, the President, Multi-Disciplinary Oncology at Varian, architects the integrated approach to cancer treatment by combining software, hardware, and clinical services. Overseeing the expansion of comprehensive oncology solutions, the President, Multi-Disciplinary Oncology directs the integration of diverse treatment modalities into a unified clinical workflow. This leadership role involves managing the strategic growth of the division to address the complex requirements of modern healthcare systems. By championing interdisciplinary collaboration, Andrew Shogan directly impacts the efficiency of patient care pathways. Shogan coordinates with global stakeholders to implement scalable oncology solutions that improve treatment accuracy and patient throughput. Through the oversight of multi-disciplinary initiatives, the President, Multi-Disciplinary Oncology ensures that the company provides holistic support to medical institutions. This focus on integrated care delivery strengthens the market presence of the organization and enhances the ability of clinicians to provide effective, personalized cancer treatments.
Stephen Jamison - President, Proton Solutions At Varian, A Siemens Healthineers Company
Stephen Jamison, the President, Proton Solutions At Varian, A Siemens Healthineers Company at Varian, leads the development and deployment of advanced proton therapy systems. Overseeing the technical and commercial aspects of proton beam technology, the President, Proton Solutions At Varian, A Siemens Healthineers Company directs the expansion of this specialized treatment modality into new clinical markets. This leadership role involves managing complex infrastructure projects and ensuring that proton therapy systems meet the highest standards of precision and reliability. By driving innovation in particle therapy, Stephen Jamison directly impacts the availability of targeted cancer treatments. Jamison coordinates with global health systems to facilitate the adoption of proton solutions, ensuring that clinical partners receive comprehensive support. Through the strategic management of the proton portfolio, the President, Proton Solutions At Varian, A Siemens Healthineers Company secures the long-term growth of this critical business segment, ultimately enhancing the capacity of healthcare providers to deliver life-saving care.
Amy Choi - Chief of Staff, MDO
Amy Choi, the Chief of Staff, MDO at Varian, manages strategic initiatives and facilitates communication across the Multi-Disciplinary Oncology division. Overseeing the execution of high-priority projects, the Chief of Staff, MDO ensures that departmental goals align with the broader mission of advancing cancer treatment software and hardware. This leadership role involves synthesizing complex data from various clinical streams to support executive decision-making processes. By fostering collaboration between research, development, and commercial teams, Amy Choi directly impacts the agility of the organization. Choi coordinates internal resources to address emerging market needs in proton therapy and radiosurgery. Through the management of organizational workflows, the Chief of Staff, MDO secures the successful implementation of long-term strategic plans, ensuring that the division remains focused on delivering innovative medical solutions that enhance patient care and clinical efficiency on a global scale.
Dee Khuntia - Senior Vice President, Medical Affairs & Chief Medical Officer
Dee Khuntia, the Senior Vice President, Medical Affairs & Chief Medical Officer at Varian, leads clinical strategy and ensures the scientific integrity of all radiotherapy and oncology solutions. Overseeing global medical engagement, the Senior Vice President, Medical Affairs & Chief Medical Officer directs the translation of clinical research into practical medical device applications. This leadership role involves collaborating with healthcare providers to validate the efficacy of proton therapy and brachytherapy systems. By bridging the gap between engineering innovation and clinical practice, Dee Khuntia directly impacts the safety and performance of medical technologies. Khuntia guides the development of evidence-based protocols that support clinicians in treating complex medical conditions. Through the oversight of medical affairs, the Senior Vice President, Medical Affairs & Chief Medical Officer maintains the reputation of the company as a trusted partner in the global oncology community, ensuring that every product meets the highest standards of patient care.
Explore Leadership Teams in Manufacturing
Founded in 1919, Ottobock is a German family-owned prosthetics company that provides medical technology solutions. Products include lightweight, active, and power wheelchairs, pediatric rehabilitation products, and seating shell systems. Otto Bock also offers polyurethane foams, foam systems for the automotive industry, and information and communication technology. The company is headquartered in Duderstadt, Germany.
Company Leadership OT
HR
WC
Globus Medical specializes in developing, manufacturing, and distributing innovative musculoskeletal device solutions aimed at improving patient care. Their extensive product portfolio includes advanced technologies for spine procedures, orthopedic trauma, joint reconstruction, and regenerative biologics. The company serves healthcare professionals and surgeons by providing comprehensive educational resources and clinical support. Globus Medical is committed to addressing unmet clinical needs and enhancing surgical practices through cutting-edge technology and solutions.
Company Leadership
KK
NJ
BE
InMode Ltd. is a publicly traded medical technology company headquartered in Yokneam, Israel, with a US headquarters in Irvine, California. Founded in 2008, InMode designs, develops, and manufactures minimally invasive and non-invasive aesthetic medical devices using proprietary radiofrequency, laser, and light-based technologies. Its platforms, including Morpheus8, BodyTite, and FaceTite, serve plastic surgeons, dermatologists, OB/GYNs, and medspas, treating face and body contouring, skin tightening, hair removal, and women's wellness in over 80 countries worldwide.
Company Leadership
EK

NT
Meiban is a global contract development and manufacturing organization (CDMO) specializing in the medtech and regulated industries, offering a unique combination of product development and precision manufacturing. With over 40 years of experience, Meiban provides comprehensive services including design, engineering, and full product assembly across its nine global facilities. The company focuses on delivering innovative solutions for diagnostics, life sciences, medical devices, and cell & gene therapy sectors. Meiban's commitment to quality and compliance is underscored by its adherence to various international standards and its fully digitized iSmart factory.
Company Leadership GG
KC
CM